Immune Biosolutions

Recombinant antibodies for cancer, GI diseases.

placeSherbrooke, Quebec, Canada calendar_todayFounded 2012 groups29 employees language immunebiosolutions.com

Innovation

4 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 132 times.

YearFilings
20161
20181
20202
20212
20232
20261

Social engagement

Social engagement: 2.6K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Accelerator & incubator120%
Other / undisclosed240%

Recent activity

23 Jan 2026
Product launch
SARS-CoV-2 (CV3-25) antibodies
11 Sep 2025
Event
BioProcess International 2025
Coming soon